Clinical Trial Update: Experimental Vaccine for Malaria in Adults in Mali [Phase 1]

View source ↗

Summary

A Phase 1 trial of an experimental malaria vaccine conducted in adults in Mali has completed, sponsored by NIAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Experimental malaria vaccine (Phase 1)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED